Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, October 25, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Selina Secures $147.5 Million Convertible Note Financing in Connection with its Planned Business Combination with BOA Acquisition Corp.
Life Sciences Times
-
April 25, 2022
0
Venture Capital
Silence Therapeutics Achieves $2 Million Research Milestone in Hansoh Pharma Collaboration
Life Sciences Times
-
April 25, 2022
0
Venture Capital
Octant Raises $80 Million Series B Round to Support Expansion of Next-Generation Drug Discovery Platform, Announces Collaboration with Bristol Myers Squibb and Key Appointments
Life Sciences Times
-
April 21, 2022
0
Venture Capital
Reify Health Raises $220M Series D to Bridge the Diversity Gap in Clinical Trials
Life Sciences Times
-
April 21, 2022
0
Venture Capital
Levels $38M Series A Driven by Member and Community Alignment to Solve Metabolic Health Crisis
Life Sciences Times
-
April 20, 2022
0
Venture Capital
d-Matrix Announces $44 Million in Funding to Build a One-of-a-Kind Compute Platform Targeted for At-Scale Transformer AI Datacenter Inference
Life Sciences Times
-
April 20, 2022
0
Venture Capital
Carlsmed Raises $30M in Series B Funding to Scale Personalized Spine Surgery
Life Sciences Times
-
April 19, 2022
0
Venture Capital
Tessera Therapeutics Announces Over $300M Series C Financing to Advance its GENE WRITING Platform
Life Sciences Times
-
April 19, 2022
0
Venture Capital
Unlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs™ in Clinical Trials
Life Sciences Times
-
April 19, 2022
0
Venture Capital
Blue Spark Technologies Raises $40 Million in Growth Funding Led by Ghost Tree Partners to Advance AI-Based Remote Patient Monitoring
Life Sciences Times
-
April 18, 2022
0
Venture Capital
Be Bio Closes $130 Million Financing to Pioneer Engineered B Cells, a New Class of Cellular Medicines
Life Sciences Times
-
April 14, 2022
0
Venture Capital
GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn
Life Sciences Times
-
April 13, 2022
0
1
...
78
79
80
...
115
Page 79 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026